U.S. Food and Drug Administration

• A letter to our new U.S. Department of Health and Human Resources Secretary Robert F. Kennedy, Jr.
• Government will conduct abortion pill review amid studies showing possible dangers
• Groundbreaking study finds abortion pill 22 times more dangerous than FDA says
• Hawley hauls the FDA toward accountability on the abortion drug
• In addition to FDA v. AHM there are other critical cases involving the abortion pill
• New study reveals FDA relied on cherrypicked data to approve dangerous mail-order abortion drugs
• Pro-life leaders urge Trump FDA to reinstate abortion pill safeguards after alarming study's release
• Robert F. Kennedy Jr. says FDA should change label on abortion pill, promises full review of health effects
• SCOTUS says pro-life doctors lack standing on abortion drug concerns, upholds federal conscience protections
• Sen. Hawley slams FDA head for saying he has ‘no plans’ to restrict abortion pills
• States claim economic harm from abortion pill; case revived after doctors’ legal loss
• The abortion landscape is changing. So is the pro-life response.
• Three states sue FDA for ‘disregarding the health and safety’ of women with abortion pill expansion
• Trump FDA nominee says he'll review in-person dispensing of mifepristone